[go: up one dir, main page]

PL1885342T3 - Inhibitor krystalizacji i jego zastosowanie w kapsułkach żelatynowych - Google Patents

Inhibitor krystalizacji i jego zastosowanie w kapsułkach żelatynowych

Info

Publication number
PL1885342T3
PL1885342T3 PL06738862.9T PL06738862T PL1885342T3 PL 1885342 T3 PL1885342 T3 PL 1885342T3 PL 06738862 T PL06738862 T PL 06738862T PL 1885342 T3 PL1885342 T3 PL 1885342T3
Authority
PL
Poland
Prior art keywords
gelatin capsules
crystallization inhibitor
crystallization
inhibitor
capsules
Prior art date
Application number
PL06738862.9T
Other languages
English (en)
Inventor
Tomas Andrysek
Ales Vrana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36675980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1885342(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of PL1885342T3 publication Critical patent/PL1885342T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
PL06738862.9T 2005-03-21 2006-03-16 Inhibitor krystalizacji i jego zastosowanie w kapsułkach żelatynowych PL1885342T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US66482605P 2005-03-21 2005-03-21

Publications (1)

Publication Number Publication Date
PL1885342T3 true PL1885342T3 (pl) 2016-10-31

Family

ID=36675980

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06738862.9T PL1885342T3 (pl) 2005-03-21 2006-03-16 Inhibitor krystalizacji i jego zastosowanie w kapsułkach żelatynowych

Country Status (10)

Country Link
US (1) US8673351B2 (pl)
EP (1) EP1885342B8 (pl)
CN (1) CN101141953A (pl)
CO (1) CO6321129A2 (pl)
ES (1) ES2573539T3 (pl)
HU (1) HUE029192T2 (pl)
IL (1) IL185729A0 (pl)
MX (1) MX2007011250A (pl)
PL (1) PL1885342T3 (pl)
WO (1) WO2006102157A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8277839B2 (en) * 2006-07-06 2012-10-02 Ares Trading S.A. Oral pharmaceutical composition of anilinopyrimidine, preparation and use thereof
US9011908B2 (en) 2009-04-06 2015-04-21 Banner Life Sciences Llc Progesterone solutions for increased bioavailability
CN101721931B (zh) * 2009-11-26 2012-08-08 广州普正生物科技有限公司 一种多相混悬系统及其制备方法与应用
US8900631B2 (en) 2011-04-28 2014-12-02 Health Science Funding, LLC Dosage form to increase prasterone bioavailability
WO2013144976A2 (en) * 2012-03-28 2013-10-03 Medreich Limited Chewable soft gelatin capsule dosage form of mucolytic agents
WO2015022349A1 (en) * 2013-08-14 2015-02-19 Ratiopharm Gmbh Dosage form comprising enzalutamide
WO2016071515A1 (en) * 2014-11-07 2016-05-12 Sigmoid Pharma Limited Compositions comprising cyclosporin
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
AU2020219240A1 (en) * 2019-02-06 2021-08-26 Emerald Health Pharmaceuticals Inc. Formulations of cannabidiol derivatives and their use as modulators of cannabinoid receptor type 2 (CB2)
EP3955919A1 (en) 2019-04-17 2022-02-23 COMPASS Pathfinder Limited Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
GB8903804D0 (en) 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
DE68900991D1 (de) 1988-01-29 1992-04-23 Sankyo Co Cyclosporin-zusammensetzungen.
FR2683225B1 (fr) 1991-10-31 1993-12-31 Gattefosse Sa Procede pour ameliorer une huile glycerolysee.
DE4221491C2 (de) 1992-06-29 1994-09-29 Pohl Boskamp Gmbh Chem Pharma Verfahren zur Herstellung von Weichgelatinekapseln
DK0649651T3 (da) 1993-09-28 2001-02-26 Scherer Gmbh R P Fremstilling af bløde gelatinekapsler
GB9405304D0 (en) 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
JPH10211425A (ja) * 1997-01-29 1998-08-11 Fuji Capsule Kk カプセルの乾燥方法
WO1998038984A2 (en) * 1997-03-05 1998-09-11 Sugen, Inc. Formulations for hydrophobic pharmaceutical agents
US6063762A (en) 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
ID25908A (id) 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
EP1067908B9 (en) * 1998-04-01 2007-01-24 Jagotec Ag Taxane microemulsions
JP3500313B2 (ja) * 1998-10-27 2004-02-23 花王株式会社 カプセル粒子の水分除去方法
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
US20030235595A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
US20020049157A1 (en) 1999-08-25 2002-04-25 Jiangping Wu Use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
PT1318791E (pt) * 2000-09-22 2004-11-30 Galephar M F Composicao farmaceutica semi-solida de isotretinoina
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US20040033257A1 (en) * 2002-05-30 2004-02-19 Strides Inc. Pharmaceutical formulation in a drug delivery system and process for preparing the same
GB2391472B (en) * 2002-08-02 2004-12-08 Satishchandra Punambhai Patel Pharmaceutical compositions
GB2391473B (en) * 2002-08-02 2004-07-07 Satishchandra Punambhai Patel Pharmaceutical compositions
US7025911B2 (en) * 2002-09-13 2006-04-11 Freund Corporation Manufacturing method for oral quick-dissolving seamless capsule
JP2004262774A (ja) * 2003-02-20 2004-09-24 Freunt Ind Co Ltd シームレスカプセル
IL159729A0 (en) * 2004-01-06 2004-06-20 Doron I Friedman Non-aqueous composition for oral delivery of insoluble bioactive agents
US20050220825A1 (en) * 2004-03-10 2005-10-06 Adrian Funke Molecular dispersions of drospirenone

Also Published As

Publication number Publication date
EP1885342B8 (en) 2016-06-22
ES2573539T3 (es) 2016-06-08
EP1885342B1 (en) 2016-03-09
EP1885342A1 (en) 2008-02-13
IL185729A0 (en) 2008-01-06
CO6321129A2 (es) 2011-09-20
US20110020438A1 (en) 2011-01-27
HUE029192T2 (en) 2017-02-28
US8673351B2 (en) 2014-03-18
MX2007011250A (es) 2007-11-14
WO2006102157A1 (en) 2006-09-28
CN101141953A (zh) 2008-03-12

Similar Documents

Publication Publication Date Title
IL185729A0 (en) Crystallization inhibitor and its use in gelatin capsules
EP1747299A4 (en) DEVICES AND METHODS USING ONE-CRYSTAL FORM MEMORY ALLOYS
IL185280A0 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
ZA200709854B (en) 17ß-HSD1 and STS inhibitors
EP1951680A4 (en) NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE
IL187776A0 (en) Benzamide derivatives and uses related thereto
ZA200704718B (en) Compositions and methods for reducing the transmissivity of illnesses
IL190955A0 (en) Dicarboxylic acid derivatives and their use
HK1101911A1 (en) Tetrahydrocarbozoles and derivatives
DK2258219T3 (da) Næring med lipider og ufordøjelige saccharider
IL187463A0 (en) Proteasome inhibitors and uses thereof
GB0512940D0 (en) Compounds and their use
IL189252A0 (en) Dihydroxyanthraquinones and their use
IL178888A0 (en) Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
ZA200805386B (en) MIF inhibitors
EP2097378A4 (en) NOVEL INHIBITORS OF SEH AND USE THEREOF
GB0516069D0 (en) Pharmaceutical and use thereof
GB0520743D0 (en) Compounds and their use
PT2380575E (pt) Acetato de eslicarbazepina e utilização
EP1866723A4 (en) DEVICE FOR REDUCING RISK WHEN SELLING A PROPERTY
EP1930406A4 (en) IN THE BRAIN WALKING CELL AND USE THEREOF
GB2425708B (en) Bracelet and use thereof
GB0506249D0 (en) Pharses and word
ZA200706741B (en) Tetrahydroindolone and tetrahydroindazolone derivatives
IL177271A0 (en) Heparanase inhibitors and uses thereof